XERS NASDAQ · Healthcare · FY 2025-12-31
Xeris Biopharma Holdings, Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Unknown
Buy zone
Unknown
Archetype
Distressed/Deficit
Confidence
○○○
Insufficient · 0/4
Price
8.080 USD
Market cap
1.34B USD
P / B
98.11
P / E
—
EPS
0.000
DPS / yield
— (0.0%)
NAV / share
-0.585
Graham number
—
Z'' score
-2.91
Piotroski F
8 / 9
Beneish M
-2.57
ROIC vs WACC
16.8%
vs 10.1%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.